by Carlos Ramirez-Mejia | Sep 14, 2026 | Alzheimer, Deficit de Atención, Neurología General
Two recent developments are changing how neurology approaches Alzheimer’s disease: a blood test that can predict risk up to 10 years in advance, and progress in medications targeting one of its two main drivers. In a recent TV segment, I discussed both findings...
